Maximum quantity allowed is 999
请选择数量
CAS RN: 212322-56-0 | 产品编码: E1033
Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate
![Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate Chemical Structure of Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate](/medias/E1033.jpg?context=bWFzdGVyfHJvb3R8NDEwNjR8aW1hZ2UvanBlZ3xhREJpTDJnMU5TODRPVEl4TmpFNE56RXdOVFU0TDBVeE1ETXpMbXB3Wnd8NmU1YTNkOWVlYmI2MjkyYjQwMGIxNjU4MmZiNmJmYjAxNDgxODZhYTRiMmVjOTc3NDQxMGQwNDZlYzczNjJlYg)
技术规格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 104.0 to 108.0 °C |
物性(参考值)
熔点 | 106 °C |
溶解性(可溶于) | 甲醇 |
GHS
相关法规
运输信息
HS编码* | 2933.39-000 |
应用
A Synthetic Intermediate of Dabigatran and Its Derivatives
This product has been used as a synthetic intermediate of dabigatran [D5902, D5904 (Etexilate)] and its derivatives, which are direct thrombin inhibitors.
References
- Structure-based design of novel potent nonpeptide thrombin inhibitors
- Synthesis, characterization and suppression of impurities during optimization of Dabigatran etexilate
- Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors
- Gradient RP-HPLC method for the determination of potential impurities in dabigatran etexilate in bulk drug and capsule formulations
参考文献
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。